Beth L. Laube received her Ph.D. from the Johns Hopkins Bloomberg School of Public Health and is currently Professor Emerita at the Johns Hopkins School of Medicine. Dr. Laube’s research is translational in nature and is centered on in vivo and in vitro quantification of the deposition and removal of particles in healthy and diseased lungs and noses, using radiolabeled aerosols and scintigraphic imaging assessments. This approach has been very useful in the development of aerosol therapies for asthma, cystic fibrosis and diabetes and for answering basic physiologic questions about mucociliary clearance. She has been a member of the Editorial Board of the Journal of Aerosol Medicine (now the Journal of Aerosol Medicine and Pulmonary Drug Delivery) since 1998. From 2003-2007, she participated in the World Health Organization’s Product Development Group for Aerosolized Measles Vaccine.
From 2005-2007, she served as President of the International Society for Aerosols in Medicine (ISAM). In 2021, she was given ISAM’s Willi Stahlhofen Award for outstanding experimental research in aerosols in medicine. She is a frequent advisor to pre-doctoral students and post-doctoral fellows and has published over 60 peer-reviewed articles.
